Optogenetics Clinical Trial Restores Sight to Blind Patients
A clinical trial using optogenetics based on 2026 Nobel Prize research enabled hereditary blind patients to regain partial vision.
A clinical trial using optogenetics based on 2026 Nobel Prize research enabled hereditary blind patients to regain partial vision.